EAAT2 Expression in the Hippocampus, Subiculum, Entorhinal Cortex and Superior Temporal Gyrus in Alzheimer's Disease

被引:12
|
作者
Yeung, Jason H. Y. [1 ]
Palpagama, Thulani H. [1 ]
Wood, Oliver W. G. [1 ]
Turner, Clinton [2 ]
Waldvogel, Henry J. [1 ]
Faull, Richard L. M. [1 ]
Kwakowsky, Andrea [1 ]
机构
[1] Univ Auckland, Dept Anat & Med Imaging, Ctr Brain Res, Fac Med & Hlth Sci, Auckland, New Zealand
[2] Auckland City Hosp, Dept Anat Pathol, LabPlus, Auckland, New Zealand
关键词
glutamate transporter; EAAT2; hippocampus; subiculum; entorhinal cortex; superior temporal gyrus; Alzheimer's disease;
D O I
10.3389/fncel.2021.702824
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alzheimer's disease (AD) is a neuropathological disorder characterized by the presence and accumulation of amyloid-beta plaques and neurofibrillary tangles. Glutamate dysregulation and the concept of glutamatergic excitotoxicity have been frequently described in the pathogenesis of a variety of neurodegenerative disorders and are postulated to play a major role in the progression of AD. In particular, alterations in homeostatic mechanisms, such as glutamate uptake, have been implicated in AD. An association with excitatory amino acid transporter 2 (EAAT2), the main glutamate uptake transporter, dysfunction has also been described. Several animal and few human studies examined EAAT2 expression in multiple brain regions in AD but studies of the hippocampus, the most severely affected brain region, are scarce. Therefore, this study aims to assess alterations in the expression of EAAT2 qualitatively and quantitatively through DAB immunohistochemistry (IHC) and immunofluorescence within the hippocampus, subiculum, entorhinal cortex, and superior temporal gyrus (STG) regions, between human AD and control cases. Although no significant EAAT2 density changes were observed between control and AD cases, there appeared to be increased transporter expression most likely localized to fine astrocytic branches in the neuropil as seen on both DAB IHC and immunofluorescence. Therefore, individual astrocytes are not outlined by EAAT2 staining and are not easily recognizable in the CA1-3 and dentate gyrus regions of AD cases, but the altered expression patterns observed between AD and control hippocampal cases could indicate alterations in glutamate recycling and potentially disturbed glutamatergic homeostasis. In conclusion, no significant EAAT2 density changes were found between control and AD cases, but the observed spatial differences in transporter expression and their functional significance will have to be further explored.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] MRI of entorhinal cortex and hippocampus in Alzheimer's disease, subcortical ischemic vascular dementia and mixed dementia
    Schuff, N
    Du, AT
    Amend, D
    Hsu, YY
    Laakso, MP
    Jagust, W
    Chui, HC
    Weiner, MW
    ALZHEIMER'S DISEASE: ADVANCES IN ETIOLOGY, PATHOGENESIS AND THERAPEUTICS, 2001, : 229 - 236
  • [42] nNOS expression in reactive astrocytes correlates with increased cell death related DNA damage in the hippocampus and entorhinal cortex in Alzheimer's disease
    Simic, G
    Lucassen, PJ
    Krsnik, Z
    Kruslin, B
    Kostovic, I
    Winblad, B
    Bogdanovic, N
    EXPERIMENTAL NEUROLOGY, 2000, 165 (01) : 12 - 26
  • [43] Key Disease Mechanisms Linked to Alzheimer's Disease in the Entorhinal Cortex
    Bottero, Virginie
    Powers, Dallen
    Yalamanchi, Ashna
    Quinn, James P.
    Potashkin, Judith A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (08)
  • [44] Dysregulated Transcript Expression but Not Function of the Glutamate Transporter EAAT2 in the Dorsolateral Prefrontal Cortex in Schizophrenia
    O'Donovan, Sinead M.
    Shan, Dan
    Wu, Xiaojun
    Choi, Jae Hyuk
    McCullumsmith, Robert E.
    SCHIZOPHRENIA BULLETIN, 2024,
  • [45] Vulnerability of the entorhinal cortex II to neurodegeneration in Alzheimer's disease
    Reyes-Pablo, Aldelmo Emmanuel
    Luna-Viramontes, Nabil Itzi
    Montiel-Sosa, Jose Francisco
    Ontiveros-Torres, Miguel angel
    Garces-Ramirez, Linda
    de la Cruz-lopez, Fidel
    Apatiga-Perez, Ricardo
    Villanueva-Fierro, Ignacio
    Hernandes-Alejandro, Mario
    Jaramillo-Loranca, Blanca Estela
    Vargas-Hernandez, Genaro
    Pacheco-Herrero, Mar
    Luna-Munoz, Jose
    BRAIN COMMUNICATIONS, 2025, 7 (02)
  • [46] Impairment of entorhinal cortex network activity in Alzheimer's disease
    Karimani, Farnaz
    Asgari Taei, Afsaneh
    Abolghasemi-Dehaghani, Mohammad-Reza
    Safari, Mir-Shahram
    Dargahi, Leila
    FRONTIERS IN AGING NEUROSCIENCE, 2024, 16
  • [47] An Entorhinal Cortex Sulcal Pattern is Associated with Alzheimer's Disease
    Zhan, Jiong
    Brys, Miroslaw
    Glodzik, Lidia
    Tsui, Wai
    Javier, Elizabeth
    Wegiel, Jerzy
    Kuchna, Lzabela
    Pirraglia, Elizabeth
    Li, Yi
    Mosconi, Lisa
    Saint Louis, Leslie A.
    Switalski, Remigiusz
    De Santi, Susan
    Kim, Byeong C.
    Wisniewski, Thomas
    Reisberg, Barry
    Bobinski, Matthew
    de Leon, Mony J.
    HUMAN BRAIN MAPPING, 2009, 30 (03) : 874 - 882
  • [48] Alzheimer's Disease Connected Genes in the Post-Ischemic Hippocampus and Temporal Cortex
    Pluta, Ryszard
    GENES, 2022, 13 (06)
  • [49] Impaired Expression of GABA Signaling Components in the Alzheimer's Disease Middle Temporal Gyrus
    Govindpani, Karan
    Turner, Clinton
    Waldvogel, Henry J.
    Faull, Richard L. M.
    Kwakowsky, Andrea
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (22) : 1 - 19
  • [50] Paucity of Entorhinal Cortex Pathology of the Alzheimer's Type in SuperAgers with Superior Memory Performance
    Gefen, Tamar
    Kawles, Allegra
    Makowski-Woidan, Beth
    Engelmeyer, Janessa
    Ayala, Ivan
    Abbassian, Payam
    Zhang, Hui
    Weintraub, Sandra
    Flanagan, Margaret E.
    Mao, Qinwen
    Bigio, Eileen H.
    Rogalski, Emily
    Mesulam, M. Marsel
    Geula, Changiz
    CEREBRAL CORTEX, 2021, 31 (07) : 3177 - 3183